跳至主要内容
临床试验/CTRI/2020/12/029563
CTRI/2020/12/029563尚未招募不适用

An observational study of High Flow Nasal Oxygen Therapy in COVID-19 patients admitted in intensive care unit

Not applicable1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年10月12日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Whether high flow nasal oxygen therapy can treat hypoxia in COVID 19 patients

研究概览

简要总结

This is an observational study of  the utility of HFNO therapy in managing respiratory failure in moderate to severe COVID 19 patients who are admitted in intensive care unit and also to identify the early predictors of HFNO failure.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •1.Patients between age 18-60years 2.Both males and females 3.Patients with type 1 respiratory failure 4.Patients with SpO2 less than or equal to 92% on room air 5.Patients with or without co morbidities.

排除标准

  • •1.Patient’s refusal for HFNO 2.Patients below 18years and above 60years
  • •Patients with tracheostomy
  • •Patients with Claustrophobia 5.Patients with urgent need for endotracheal intubation 6.Patients with GCS less than 8 or raised intracranial tension 7.Patients with upper airway obstruction
  • •Pregnant patients.

结局指标

主要结局

Whether high flow nasal oxygen therapy can treat hypoxia in COVID 19 patients

时间窗: During ICU stay

次要结局

  • 1.To analise failure rate of high flow nasal oxygen therapy in COVID 19 patients and escalation to invasive and non-invasive ventilation.(during ICU stay)

研究者

发起方
Not applicable
申办方类型
Other [Not applicable ]

研究点 (1)

Loading locations...

相似试验